Skip to Main Content

Paper Details

Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study.
Am J Gastroenterol
5
2023
Author NameAffiliation
Neeraj NarulaDepartment of Medicine (Division of Gastroenterology) and Farncombe Family Digestive Health Research Institute, McMaster University
Vipul JairathWestern University
Parambir S DulaiNorthwestern University
  • 1 - 3

Datasets

Release 1.2